Form 4: 2seventy bio Director Sells 3,900 Shares in Open Market Transaction

Marcela V. Maus, a director at 2seventy bio, sold 3,900 shares of common stock at an average price of $3.3801 per share on November 18, 2024.

Summary

• Marcela V. Maus, a director of 2seventy bio, sold 3,900 shares of the company's common stock on November 18, 2024.
• The shares were sold at a weighted average price of $3.3801 per share.
• The sale was executed in multiple transactions with prices ranging from $3.37 to $3.39 per share.
• Following the transaction, Ms. Maus directly owns 23,752 shares of 2seventy bio common stock.

Sentiment

Score: 5

Explanation: The document is a neutral disclosure of a stock sale by a director. It doesn't indicate positive or negative sentiment about the company's performance.

Industry Context

This is a routine disclosure of an insider transaction, which is common for publicly traded companies. It provides transparency into the trading activities of company directors.

Comparison to Industry Standards

• Insider trading disclosures are a standard practice for all publicly listed companies in the US.
• The reporting requirements are governed by the Securities and Exchange Commission (SEC).
• Similar filings are made by directors and officers of companies like Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX) when they trade their company's stock.

Stakeholder Impact

• The sale of shares by a director may have a minor impact on investor sentiment, but is unlikely to have a significant impact on the company's operations or financial health.

Key Dates

Keywords

2seventy bio, TSVT, insider trading, stock sale, director, Marcela V. Maus, SEC Form 4